Related Experiment Videos
Exploring a new twist on tumor metastasis.
Jing Yang1, Sendurai A Mani, Robert A Weinberg
1Whitehead Institute for Biomedical Research, Cambridge Center, Cambridge, Massachusetts 02142, USA.
Cancer Research
|May 3, 2006
Summary
Understanding the transcription factor Twist and epithelial-mesenchymal transition is key to limiting cancer metastasis. This review explores their roles in normal development and tumor progression.
Area of Science:
- Oncology
- Developmental Biology
- Molecular Biology
Background:
- Cancer metastasis is a major cause of cancer-related deaths.
- The transcription factor Twist plays a role in tumor cell metastasis.
- Epithelial-mesenchymal transition (EMT) is a process involved in metastasis.
Purpose of the Study:
- To review the Twist signaling pathway during normal development.
- To discuss the role of Twist and EMT in tumor metastasis.
Main Methods:
- Literature review of studies on Twist signaling and EMT.
- Analysis of the biological functions of Twist and EMT in cancer.
Main Results:
- Twist regulates epithelial-mesenchymal transition.
- Twist is involved in early embryonic morphogenesis.
- EMT and Twist play critical roles in tumor metastasis.
Conclusions:
- Understanding the genetic programs driving metastasis, particularly the Twist pathway and EMT, is crucial for developing strategies to prevent or limit cancer spread.
- Targeting Twist and EMT may offer therapeutic avenues for cancer treatment.